Johnson & Johnson, DEF 14A (March 16, 2022)

This year, shareholders, from pharmaceutical company Johnson & Johnson, supported a proxy proposal to conduct a racial equity audit.

Read More: https://www.intelligize.com/2022-proxy-season-in-review-more-shareholder-proposals-less-support/